Asia Strategy on the Research and Development and Regulation for the Modernization of Herbal Medicine

This session will share the experience on possible resolution on the quality control, the interaction of botanical drugs with western medicine and the R&D strategy and the approval of the first NDA on botanical drugs in Taiwan.

Objective:
Describe the research and development as well as strategy of herbal medicine in Asia; Recognize the drug-drug interaction between botanical drug and western medicine

Presentation(s) & Speaker(s):
Regulatory Aspect of CMC Issues on Development of Botanical Drugs
I-Chen Sun, PhD
Reviewer
Center for Drug Evaluation
Taiwan

Natural Products Significantly Inhibit Five Phase 1 and Phase 2 Hepatic Enzymes
Oliver Yoa-Pu Hu, PhD
Dean, Research and Development
National Defense Medical Center
Taiwan

Strategy on the Research and Development and Regulation for Herbal Medicine
Shiouh-Yi Chen, PhD
Senior Officer
Center For Drug Evaluation
Taiwan

http://www.diahome.org/DIAHome/FlagshipMeetings/SearchSesTut.aspx?meetin...